CLINICAL_TRIALS
withdrawal
· 2018-07-16
Clinical Trial Update: A Phase Ib Study of NVX-508 in Sickle Cell Disease [Phase 1]
Summary
The Phase Ib trial of NVX-508 in sickle cell disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amma Owusu-Ansah, MD | Conditions: Sickle Cell Disease | Phase 1 | Status: WITHDRAWN